Shares ofTelesis Bio, Inc.(NASDAQ:TBIO) rose sharply in today's pre-market trading session after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.

Telesis Bio reached a new partnership with laboratory automation and innovation company Beckman Coulter Life Sciences to create efficient and scalable biofoundries and deliver solutions for DNA synthesis.

Telesis Bio shares jumped 109.9% to $4.87 in the pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Kintara Therapeutics, Inc. (NASDAQ:KTRA) rose 41.8% to $0.2375 in pre-market trading. Kintara Therapeutics recently announced adjournment of special...